✦ LIBER ✦

FMISO-PET as Biomarker of Early Response to Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

✍ Scribed by Arvold, N.D.; Heidari, P.; Kunawudhi, A.; Sequist, L.V.; Mahmood, U.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR mutants found in non-small cell lun

✍ Fu, Y-N; Yeh, C-L; Cheng, H H-Y; Yang, C-H; Tsai, S-F; Huang, S-F; Chen, Y-R 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 225 KB

58PD NANOSTRING MULTIPLE TARGET PROFILIN

✍ Rosell, R.; Taron, M.; Benlloch, S.; Costa, C.; Santarpia, M.; Moran, T.; Carcer 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 75 KB

FDG-PET as a pharmacodynamic biomarker f

✍ Mudd, Sarah R.; Voorbach, Martin J.; Reuter, David R.; Tapang, Paul; Hickson, Jo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 237 KB

9027 Patient-derived tumourgrafts of non

✍ Fichtner, I.; Rolff, J.; Merk, J.; Soong, R.; Lamich, A.; Rivera, M.; Becker, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Early Prediction of Response to Anticanc

✍ D.H. Lee; S.K. Kim; J.-Y. Han; H.T. Kim; J.S. Lee; S.H. Lee; E.K. Cho; J.S. Lee 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Usefulness of FDG-PET for early predicti

✍ Sunaga, Noriaki; Oriuchi, Noboru; Kaira, Kyoichi; Yanagitani, Noriko; Tomizawa, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 937 KB